Observational studyActa oncologica (Stockholm, Sweden)2025

Real-world outcomes of 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer: the KuPSMALu trial in Eastern Finland.

Okko-Sakari Kääriäinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.